1. Home
  2. GMM vs VNRX Comparison

GMM vs VNRX Comparison

Compare GMM & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

N/A

Current Price

$1.35

Market Cap

39.6M

Sector

N/A

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.30

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMM
VNRX
Founded
2017
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.6M
38.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
GMM
VNRX
Price
$1.35
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.17
AVG Volume (30 Days)
15.6K
2.6M
Earning Date
08-18-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.79
N/A
Revenue
$48,171,048.00
$1,472,007.00
Revenue This Year
N/A
$55.33
Revenue Next Year
N/A
$493.79
P/E Ratio
$0.75
N/A
Revenue Growth
41.74
14.48
52 Week Low
$1.23
$0.27
52 Week High
$4.97
$0.94

Technical Indicators

Market Signals
Indicator
GMM
VNRX
Relative Strength Index (RSI) 28.52 36.84
Support Level $1.25 $0.28
Resistance Level $1.59 $0.34
Average True Range (ATR) 0.10 0.03
MACD -0.01 0.00
Stochastic Oscillator 20.52 36.58

Price Performance

Historical Comparison
GMM
VNRX

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: